Sligo General Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2007
NCT00789971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sligo General Hospital

Active Ingredients

Drugs in Other Trials (4)

neomycin (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

triamcinolone (kenalog) (1 trial)

urea (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 4